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Introduction
Polycation Avoidance in Paramecium differs widely from that of Tetrahymena
Figure 1.  Polycation avoidance in Paramecium and Tetrahymena.  Both Paramecium (A) and Tetrahymena (B) 
avoid VIP (circles), PACAP 1-27 (squares), PACAP 1-38 (diamonds), PACAP 6-27 (hexagons) and lysozyme (stars).  
Each point represents the mean ± SD of three trials.  A. The concentration of ligand required for 100% avoidance in 
Paramecium is 50 μM VIP, 10 μM for PACAP 1-27 and 1-38, and 0.5 μM for lysozyme.  We could not obtain 100% 
avoidance with PACAP 6-27 because of its toxicity.  The EC50 of these polycations in Paramecium was 
approximately 3 μM for VIP, 0.75 μM for all PACAP isoforms, and 0.1 μM for lysozyme.  B. The concentration of 
ligand required for 100% avoidance in Tetrahymena is 100 μM VIP, 0.1 μM for all PACAP isoforms, and 100 μM for 
lysozyme.  The EC50 of these polycations in Paramecium was approximately 7.5 μM for VIP, 0.05 μM for all PACAP 
isoforms, and 50 μM for lysozyme (see also Keedy et al., 2003).
Cross-Adaptation between lysozyme and members 
of the PACAP family suggest that these ligands use 
the same receptor and/or second messenger 
pathway.  
Table 1. Cells were adapted to either 0.5 μM lysozyme or 50 μM VIP 
for 15 minutes prior to exposure to 0.5 μM lysozyme, 50 μM VIP, 
10 μM PACAP 1-38, or 10 μM PACAP 1-27.  Cells were not adapted to 
any of the PACAP isoforms because prolonged exposure to high 
concentrations of PACAP is lethal to Paramecium.  Each trial 
represents 10 cells.  A minimum of three trials was conducted for each 
concentration.  These data are similar to results previously obtained for 
Tetrahymena (Keedy et al., 2003)
Lysozyme PACAP 1-38 PACAP 1-27 VIP
Lysozyme 15 ± 5%, 
N = 4
20 ± 10%, 
N = 3
20 ± 10%, 
N = 3
23.3  ± 5.8%, 
N = 3
VIP 15 ± 5%, 
N = 6
6.6 ± 5.8%, 
N = 3
16.6 ± 5.8%, 
N= 3
10 ± 0%, 
N = 3
Materials and Methods
References
Conclusions
Tetrahymena thermophila, strain B2086, and 
Paramecium tetraurelia, strain nd6, both 
generous gifts of T.M. Hennessey (SUNY 
Buffalo) were used in this study.
Behavioral studies were conducted as described 
by Hennessey et al., 1995.  Briefly, individual 
cells were transferred from buffer into the 
polycation of interest, under a dissection 
microscope.  Cells were then observed to 
determine whether backward swimming 
occurred.  Ten cells were observed for each trial.  
At least three trials were done for each 
concentration point.
When inhibitors were used, cells were exposed 
to the inhibitor for one to two hours prior to 
exposure to the polycation of interest in order to 
allow for uptake of the inhibitor.
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The Pharmacological Profiles of the Receptor Also Differ Between the Two Organisms
•The polycation receptor of Paramecium appears to have a higher 
affinity for lysozyme than for PACAP, while the polycation receptor of 
Tetrahymena has a higher affinity for PACAP than for lysozyme, as 
indicated by behavioral studies.
•Both receptors have a relatively low affinity for VIP, as indicated by 
behavioral studies.
•Both organisms show cross-adaptation between the various 
polycations tested (lysozyme, PACAP, VIP), indicating that a single 
receptor is probably interacting with all of these polycations.
•In Tetrahymena, pharmacological studies indicate that the polycation
receptor is a G-protein linked receptor.  However, in this study, G-
protein inhibitors failed to have any effect on lysozyme avoidance in 
Paramecium.
•Paramecium avoidance to lysozyme is inhibited by the tyrosine kinase
inhibitor, genistein.  This inhibitor has no effect on lysozyme/PACAP 
avoidance in Tetrahymena.
•The receptors in the two organisms exhibit very different 
characteristics, including molecular weight, interaction with ligands, and 
interaction with second messenger pathways.
Unicellular eukaryotes are complex systems, 
performing all the tasks needed for survival within the 
context of a single cell.  Protozoans, such as 
Tetrahymena and Paramecium, use chemosensory 
systems to detect food and to avoid predation.
Both Tetrahymena and Paramecium have been used 
as models for studying chemorepellents.  Lysozyme, 
ATP, and GTP have been found to have 
chemorepellent activity in both ciliates.  In 
Tetrahymena, several PACAP isoforms have been 
shown to bind to the same receptor as lysozyme, 
indicating that this receptor may be a more general 
“polycation receptor” (Keedy et al., 2003).  The 
polycation receptor in Tetrahymena appears to be a G-
protein linked receptor which activates adenylyl cyclase
and phospholipase C (Keedy et al., 2003).
The lysozyme receptors have been affinity purified 
from both Paramecium and Tetrahymena.  The 
molecular weight of the Tetrahymena protein is 
approximately 42 kD, while the molecular weight of the 
Paramecium protein is approximately 58 kD (Kuruvilla
and Hennessey, 1998).
In our current study, we examined the hypothesis that 
Paramecium have a polycation receptor similar to that 
of Tetrahymena.  We found that although both 
organisms bind similar ligands, there are multiple 
differences between the two pathways (see 
Conclusions).
Inhibitor Tetrahymena Paramecium
GDP-β-S Inhibits at 1 mM1 No effect on avoidance at 1 mM3
GP-Antagonist-2 (BIOMOL™) Toxic to cells No effect on avoidance at 100 μM3
Rp-cAMPs Inhibits at 50 μM1 No effect on avoidance at 100 μM3
Neomycin Sulfate Inhibits at 5 μM1 Inhibits electrophysiological response to 
lysozyme at 
10 μM4
U-73122 Inhibits at 1 μM2 Toxic to cells3
Genistein No effect on avoidance at 100 μg/ml1 Inhibits at 0.1 μg/ml3
Daidzein No effect on avoidance at 100 μg/ml1 No effect on avoidance at 100 μg/ml3
1Keedy et al., 2003. 2Bartholomew et al., unpublished data 3Robinette and Kuruvilla, unpublished data 4Hennessey et al., 1995
The Tyrosine Kinase Inhibitor, Genistein, Eliminates Lysozyme Avoidance in Paramecium
Table 2. Summary of Pharmacological Data in Tetrahymena and Paramecium.
Figure 2.  Genistein (closed circles) eliminates behavioral avoidance to 0.5 μM lysozymein Paramecium, 
while daidzein (closed diamonds), a control, has no effect on avoidance.  Each point represents the mean ±
SD of  ≥three trials.  Each trial consisted of ten cells which were individually scored for avoidance.
